Institutional Holdings and Trade Data for ZIOPHARM Oncology, Inc. (ZIOP)

In the past 52-week period, shares of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) have moved within the range of $3.77 to $7.88. On the stock’s most recent trading day, the company’s shares ended the regular session at $4.26, which is 45.94% higher than its 52-week high.

ZIOPHARM Oncology, Inc. (ZIOP) has demonstrated a 20-day simple moving average (SMA) of 0.50%, and a 50-day SMA of -2.62%. This public company’s current market capitalization stands at $604.75 million.

Analyzing Consensus Estimates, Sales Revenue and Net Income

Understanding Wall Street analyst’s enthusiasm for a particular stock is crucial when considering entering a position. According to the latest data, the consensus recommendation for ZIOPHARM Oncology, Inc. (ZIOP) is Outperform.

When it comes to sales data, public companies usually post revenue and earnings that are either higher or lower than the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, ZIOPHARM Oncology, Inc. (ZIOP) delivered a 1.63% surprise with its net revenue.

Meanwhile, during the same quarter ZIOPHARM Oncology, Inc. (ZIOP) delivered a -6.00% earnings surprise. Net earnings for the quarter were posted at -$0.13 per share, whereas Wall Street had forecast -$0.14 per share.

Ownership at ZIOPHARM Oncology, Inc. (ZIOP), According to Most Recent SEC Filings

A public company’s latest 13F filings tell investors important details about institutional ownership. ZIOPHARM Oncology, Inc. (ZIOP) has 0 billion shares outstanding currently, 40.26% of which belong to institutional investors. Those institutional holdings amount to $0.24 billion.

Additionally, according to the most recent 13F filing from ZIOPHARM Oncology, Inc. (ZIOP), there were 10 new positions totaling 259,040 shares of the company’s stock. There were 12 sold out positions, on the other hand, totaling 414,069 shares.

Short, Medium and Long Term Indicators

Examining a stock’s average volume in the short, medium and long term is useful to understand trading activity and investor sentiment. ZIOPHARM Oncology, Inc. (ZIOP) has had a 20-day average volume of 1,865,085 shares, with an average of 20% of short term indicators pointed at Sell.

The stock’s 50-day average volume has been 1,871,484 shares, with an average of 75% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 1,571,886 shares with 67% of long-term indicators pointing to Sell.